STTK Q3 2022 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$284M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$212,000-88.8% YoY

Gross Profit

-$19M-8797.2% margin

Operating Income

-$25M-11900.5% margin

Net Income

-$25M-11620.3% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

+324.0%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$223M

Total Liabilities

$24M

Stockholders' Equity

$199M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$212,000	$2M	-88.8%
Gross Profit	-$19M	-$13M	-40.9%
Operating Income	-$25M	-$18M	-43.5%
Net Income	-$25M	-$17M	-41.5%